Browse by category

Headline results from OASIS 1 - a phase 3a 68-week, efficacy and safety trial comparing once-daily oral semaglutide 50 mg for weight...

In January 2020, Dr Andrew Jenkinson published his best-selling book - ‘Why We Eat (Too much)?’ – in which he outlined the emerging new...

A Cleveland Clinic landmark study on obesity and cancer, led by Dr Ali Aminian, director of Cleveland Clinic’s Bariatric & Metabolic...

Regular self-monitoring behaviours and tracking tools could be the key to losing weight and keeping it off, according to research from...

A study from the University of Copenhagen shows that the hormone neurotensin may help predict whether people are able to maintain weight...

A team from the Center for Healthcare Policy and Research (CHPR) has adopted a "whole health" approach to promoting weight loss among...

Researchers from the Mayo Clinic have outlined how obesity affects the common tests used to diagnose heart disease and impacts...

Oxford Medical Products (OMP) has initiated the first human trial of Sirona, its self-expanding hydrogel capsule which aims to deliver a...

Adults with overweight or obesity who took semaglutide demonstrated short- and longer-term improvements in controlling their eating...

Versanis Bio, a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, has announced that...